Titan Pharmaceuticals
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch TTNP and buy or sell other stocks, ETFs, and their options commission-free!About TTNP
Titan Pharmaceuticals, Inc. engages in the development of therapeutics for the treatment of chronic diseases utilizing its long-term, continuous drug delivery platform, proNeura. Its lead product is probuphine, a buprenorphine implant for the maintenance treatment of opioid addiction.
CEOWeei Jye Chay
CEOWeei Jye Chay
Employees—
Employees—
HeadquartersNew York, New York
HeadquartersNew York, New York
Founded1992
Founded1992
Employees—
Employees—
TTNP Key Statistics
Market cap23.98K
Market cap23.98K
Price-Earnings ratio-0.01
Price-Earnings ratio-0.01
Dividend yield—
Dividend yield—
Average volume—
Average volume—
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$5.35
52 Week high$5.35
52 Week low$3.58
52 Week low$3.58
Stock Snapshot
As of today, Titan Pharmaceuticals(TTNP) shares are valued at $23.98. The company's market cap stands at 23.98K, with a P/E ratio of -0.01.
Titan Pharmaceuticals(TTNP) stock opened on 2026-10-18 at —. The price climbed to — and dipped to —.
The Titan Pharmaceuticals(TTNP)'s current trading volume is 0.
In the last year, Titan Pharmaceuticals(TTNP) shares hit a 52-week high of $5.35 and a 52-week low of $3.58.
In the last year, Titan Pharmaceuticals(TTNP) shares hit a 52-week high of $5.35 and a 52-week low of $3.58.
People also own
Based on the portfolios of people who own TTNP. This list is generated using Robinhood data, and it’s not a recommendation.